Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Achieving Smoking Cessation in Individuals with Schizophrenia: Special Considerations.

Cather C, Pachas GN, Cieslak KM, Evins AE.

CNS Drugs. 2017 Jun;31(6):471-481. doi: 10.1007/s40263-017-0438-8. Review.

2.

Effective Cessation Strategies for Smokers with Schizophrenia.

Evins AE, Cather C.

Int Rev Neurobiol. 2015;124:133-47. doi: 10.1016/bs.irn.2015.08.001. Epub 2015 Sep 14. Review.

PMID:
26472528
3.

Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices.

Evins AE, Cather C, Laffer A.

Harv Rev Psychiatry. 2015 Mar-Apr;23(2):90-8. doi: 10.1097/HRP.0000000000000063. Review.

4.

Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.

Evins AE, Cather C, Pratt SA, Pachas GN, Hoeppner SS, Goff DC, Achtyes ED, Ayer D, Schoenfeld DA.

JAMA. 2014 Jan 8;311(2):145-54. doi: 10.1001/jama.2013.285113.

5.

Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force [Internet].

Patnode CD, Henderson JT, Thompson JH, Senger CA, Fortmann SP, Whitlock EP.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Sep.

6.

Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.

Hays JT, Ebbert JO.

Drugs. 2010 Dec 24;70(18):2357-72. doi: 10.2165/11538190-000000000-00000. Review.

PMID:
21142259
7.

Combination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled Trial.

Brody AL, Zorick T, Hubert R, Hellemann GS, Balali S, Kawasaki SS, Garcia LY, Enoki R, Abraham P, Young P, McCreary C.

Nicotine Tob Res. 2017 Jan;19(1):68-76. Epub 2016 Aug 3.

8.

Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study.

Caponnetto P, Auditore R, Russo C, Cappello GC, Polosa R.

Int J Environ Res Public Health. 2013 Jan 28;10(2):446-61. doi: 10.3390/ijerph10020446.

9.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
10.

Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.

Koegelenberg CF, Noor F, Bateman ED, van Zyl-Smit RN, Bruning A, O'Brien JA, Smith C, Abdool-Gaffar MS, Emanuel S, Esterhuizen TM, Irusen EM.

JAMA. 2014 Jul;312(2):155-61. doi: 10.1001/jama.2014.7195.

PMID:
25005652
11.

Improved Depressive Symptoms in Adults with Schizophrenia During a Smoking Cessation Attempt with Varenicline and Behavioral Therapy.

Cather C, Hoeppner S, Pachas G, Pratt S, Achtyes E, Cieslak KM, Evins AE.

J Dual Diagn. 2017 Jul-Sep;13(3):168-178. doi: 10.1080/15504263.2017.1319585. Epub 2017 Apr 17.

PMID:
28414583
12.

Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.

Keating GM, Lyseng-Williamson KA.

Pharmacoeconomics. 2010;28(3):231-54. doi: 10.2165/11204380-000000000-00000. Review.

PMID:
20108995
13.

Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm.

Rose JE, Behm FM.

Am J Psychiatry. 2014 Nov 1;171(11):1199-205. doi: 10.1176/appi.ajp.2014.13050595.

14.

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.

Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.

J Clin Psychopharmacol. 2007 Aug;27(4):380-6.

PMID:
17632223
15.

Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.

Baker TB, Piper ME, Stein JH, Smith SS, Bolt DM, Fraser DL, Fiore MC.

JAMA. 2016 Jan 26;315(4):371-9. doi: 10.1001/jama.2015.19284.

16.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
17.

Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking.

Walker N, Howe C, Bullen C, McRobbie H, Glover M, Parag V, Williman J, Veale R, Nosa V, Barnes J.

BMC Public Health. 2011 Nov 21;11:880. doi: 10.1186/1471-2458-11-880.

18.

[Smoking reduction and temporary abstinence: new approaches for smoking cessation].

Le Houezec J, Säwe U.

J Mal Vasc. 2003 Dec;28(5):293-300. Review. French.

PMID:
14978435
19.

Smoking cessation-recent advances.

McNeil JJ, Piccenna L, Ioannides-Demos LL.

Cardiovasc Drugs Ther. 2010 Aug;24(4):359-67. doi: 10.1007/s10557-010-6246-8. Review.

PMID:
20602163
20.

Effect of nicotine replacement therapy on quitting by young adults in a trial comparing cessation services.

Buller DB, Halperin A, Severson HH, Borland R, Slater MD, Bettinghaus EP, Tinkelman D, Cutter GR, Woodall WG.

J Public Health Manag Pract. 2014 Mar-Apr;20(2):E7-E15. doi: 10.1097/PHH.0b013e3182a0b8c7.

Supplemental Content

Support Center